The state of Alabama currently has 2 active clinical trials seeking participants for Narcolepsy research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston.
Ph4 PSG Combined JZP258-407
Recruiting
This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepiness, polysomnography, and functional outcomes in patients with idiopathic hypersomnia (IH) or narcolepsy.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
04/17/2024
Locations: Sleep Disorders Center of Alabama, Birmingham, Alabama
Conditions: Idiopathic Hypersomnia, Narcolepsy
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Recruiting
The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 and type 2 narcolepsy from previous parent studies, TAK-861-2001 (NCT05687903) and TAK-861-2002 (NCT05687916).
Gender:
All
Ages:
Between 16 years and 70 years
Trial Updated:
02/15/2024
Locations: Sleep Disorders Center of Alabama, Birmingham, Alabama
Conditions: Narcolepsy Type 1, Narcolepsy Type 2